homocysteine and medroxyprogesterone

homocysteine has been researched along with medroxyprogesterone in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aybar, F; Bukulmez, O; Kabakci, G; Oto, A; Sinici, I; Tokgozoglu, L; Yarali, H; Yildirir, A	1
Kremastinos, DT; Kyriakides, ZS; Sbarouni, E	1
Bray, P; Cushman, M; Greenland, P; Hendrix, S; Hsia, J; Kooperberg, C; Lloyd-Jones, DM; Pettinger, M; Robinson, J; Rossouw, JE	1

Trials

2 trial(s) available for homocysteine and medroxyprogesterone

Article	Year
The effect of hormone replacement therapy and simvastatin on plasma homocysteine. Journal of women's health (2002), 2005, Volume: 14, Issue:2 Topics: Aged; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Homocysteine; Humans; Hypercholesterolemia; Hypolipidemic Agents; Medroxyprogesterone; Middle Aged; Simvastatin; Time Factors; Treatment Outcome	2005
Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the women's health initiative trials of hormone therapy. Archives of internal medicine, 2008, Nov-10, Volume: 168, Issue:20 Topics: Aged; Biomarkers; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Homocysteine; Humans; Hysterectomy; Inflammation; Insulin; Integrin beta3; Interleukin-6; Leukocyte Count; Matrix Metalloproteinase 9; Medroxyprogesterone; Middle Aged; Polymorphism, Genetic; Thrombosis; Triglycerides; von Willebrand Factor	2008

Article

Year

The effect of hormone replacement therapy and simvastatin on plasma homocysteine.

Journal of women's health (2002), 2005, Volume: 14, Issue:2

Topics: Aged; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Homocysteine; Humans; Hypercholesterolemia; Hypolipidemic Agents; Medroxyprogesterone; Middle Aged; Simvastatin; Time Factors; Treatment Outcome

2005

Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the women's health initiative trials of hormone therapy.

Archives of internal medicine, 2008, Nov-10, Volume: 168, Issue:20

Topics: Aged; Biomarkers; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Homocysteine; Humans; Hysterectomy; Inflammation; Insulin; Integrin beta3; Interleukin-6; Leukocyte Count; Matrix Metalloproteinase 9; Medroxyprogesterone; Middle Aged; Polymorphism, Genetic; Thrombosis; Triglycerides; von Willebrand Factor

2008

Other Studies

1 other study(ies) available for homocysteine and medroxyprogesterone

Article	Year
Effects of hormone replacement therapy on plasma homocysteine and C-reactive protein levels. Gynecologic and obstetric investigation, 2002, Volume: 53, Issue:1 Topics: Adult; C-Reactive Protein; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Homocysteine; Humans; Medroxyprogesterone; Middle Aged; Postmenopause; Progesterone Congeners; Prospective Studies	2002